Latest Breaking News On - ஷிற்ஷேந்டு முகர்ஜி - Page 4 : comparemela.com

India’s shortage of Covid-19 vaccines that precludes immediate inoculation for all adults is rooted in the Narendra Modi government’s lack of funding for key vaccines under development and evaluation, experts have said. The experts, who have tracked global vaccine efforts, said the Indian government’s lack of investments contrasted with the actions of many countries, including America and Britain, that provided advance funding to vaccine makers and signed purchase pacts with them. The Centre had last November announced a Rs 900-crore project, coordinated by the Union science ministry’s department of biotechnology, for Covid-19 vaccines. But none of this money went to either Covishield, the AstraZeneca vaccine produced by the Serum Institute of India at Pune, or Covaxin, the home-grown vaccine made by the Hyderabad-based Bharat Biotech. Instead, a part of it was given to candidate vaccines that were at more nascent stages of development.

United statesUnited kingdomNew delhiShirshendu mukherjeeJanssen johnsonKrishna udayakumarZydus cadilaNarendra modiRamanan laxminarayanNational institute of virologyUniversity of oxfordIndian council of medical researchMelinda gates foundationCentre for disease dynamics economicsBiotechnology industry research assistance councilSerum institute of india at pune